As the Founder and CEO of Sampled, a spin out of Rutgers University serving the Biopharma with early stage, discovery and translation genomics, Robin brings valuable expertise in genomics, automation-driven solutions, and integrated service models for diagnostics and therapeutic research.

Prior to joining CellCarta, Robin held executive positions at Azenta Life Sciences (formerly Brooks Automation), where he led automation, consumables, and instrument business units, driving substantial revenue growth and transforming sample management technologies. Azenta acquired FluidX where Robin was a founder and owner, developing novel consumables and Instruments for Sample Management and High Throughput Screening.

He currently serves in the ISBER (International Society for Biological and Environmental Repositories) Outstanding New Product Award Task Force. His contributions to automation, sample storage innovation, and genomics technology development are reflected in multiple patents and industry recognitions.

Robin studied Applied Biology with Biochemistry/Microbiology at Anglia Ruskin University and obtained an Executive Certificate in Management and Leadership from the MIT Sloan School of Management.